Add to ORKGPrimary progressive multiple sclerosis (PPMS) occurs in approximately 10%–15 % of the MS population and has the worst prognosis of MS subtypes. It is charac-terized by continued worsening of disease from onse
Multiple sclerosis (MS) is a neurodegenerative disor-der that typically results in white matter (WM)...
So far, clinical studies in primary progressive MS (PPMS) have failed to meet their primary efficacy...
Secondary progressive multiple sclerosis (SPMS) is diagnosed retrospectively and involves a clinical...
Primary progressive multiple sclerosis (PPMS) occurs in approximately 10%–15 % of the MS population ...
Approximately 85%-90 % of patients with multiple sclerosis (MS) will begin their disease with a cour...
Since the earliest clinical descriptions of multiple sclerosis (MS), it has been recognised that a m...
Using the term of progressive multiple sclerosis (PMS), we considered a combined population of perso...
Multiple sclerosis (MS) is an autoimmune inflammatory demyelinating disease of the central nervous s...
Background: Primary progressive multiple sclerosis (PPMS) carries the worst prognosis of the multipl...
We report a natural history study of 216 patients with primary progressive (PP)- multiple sclerosis ...
MS is an autoimmune disease, with genetic factors and environmental factors having important roles. ...
Multiple sclerosis (MS) is a chronic, inflammatory, demyelinating and neurodegenerative disease of t...
Multiple sclerosis (MS) has long been recognised to have both a relopsing-remitting and progressive ...
Background: It is unclear if all patients with relapsing remitting multiple sclerosis (RRMS) ultimat...
Multiple sclerosis (MS) is a neurodegenerative disor-der that typically results in white matter (WM)...
So far, clinical studies in primary progressive MS (PPMS) have failed to meet their primary efficacy...
Secondary progressive multiple sclerosis (SPMS) is diagnosed retrospectively and involves a clinical...
Primary progressive multiple sclerosis (PPMS) occurs in approximately 10%–15 % of the MS population ...
Approximately 85%-90 % of patients with multiple sclerosis (MS) will begin their disease with a cour...
Since the earliest clinical descriptions of multiple sclerosis (MS), it has been recognised that a m...
Using the term of progressive multiple sclerosis (PMS), we considered a combined population of perso...
Multiple sclerosis (MS) is an autoimmune inflammatory demyelinating disease of the central nervous s...
Background: Primary progressive multiple sclerosis (PPMS) carries the worst prognosis of the multipl...
We report a natural history study of 216 patients with primary progressive (PP)- multiple sclerosis ...
MS is an autoimmune disease, with genetic factors and environmental factors having important roles. ...
Multiple sclerosis (MS) is a chronic, inflammatory, demyelinating and neurodegenerative disease of t...
Multiple sclerosis (MS) has long been recognised to have both a relopsing-remitting and progressive ...
Background: It is unclear if all patients with relapsing remitting multiple sclerosis (RRMS) ultimat...
Multiple sclerosis (MS) is a neurodegenerative disor-der that typically results in white matter (WM)...
So far, clinical studies in primary progressive MS (PPMS) have failed to meet their primary efficacy...
Secondary progressive multiple sclerosis (SPMS) is diagnosed retrospectively and involves a clinical...